Abstract: The present invention concerns a monoclonal antibody and corresponding hybridoma cells and antigens suitable for isolating fetal cells from maternal blood. The inventive monoclonal antibody reacts with a surface antigen present on fetal red blood cells including their nucleated precursor cells, but not with surface antigens on adult erythroid cell.
Type:
Application
Filed:
November 18, 2022
Publication date:
October 12, 2023
Applicant:
KELLBENX INCORPORATED
Inventors:
Christiane HOLLMANN, Silke ZIMMERMANN, Stefan STACHELHAUS, Winfried ALBERT